BE1002024A6 - Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. - Google Patents

Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. Download PDF

Info

Publication number
BE1002024A6
BE1002024A6 BE8900463A BE8900463A BE1002024A6 BE 1002024 A6 BE1002024 A6 BE 1002024A6 BE 8900463 A BE8900463 A BE 8900463A BE 8900463 A BE8900463 A BE 8900463A BE 1002024 A6 BE1002024 A6 BE 1002024A6
Authority
BE
Belgium
Prior art keywords
hecogenin
treatment
derivatives
esters
benign prostatic
Prior art date
Application number
BE8900463A
Other languages
English (en)
French (fr)
Inventor
Streber August S Muhlweg
Original Assignee
Kanoldt Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanoldt Arzneimittel Gmbh filed Critical Kanoldt Arzneimittel Gmbh
Application granted granted Critical
Publication of BE1002024A6 publication Critical patent/BE1002024A6/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
BE8900463A 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. BE1002024A6 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3838716A DE3838716A1 (de) 1988-11-15 1988-11-15 Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie

Publications (1)

Publication Number Publication Date
BE1002024A6 true BE1002024A6 (fr) 1990-05-22

Family

ID=6367236

Family Applications (2)

Application Number Title Priority Date Filing Date
BE8900463A BE1002024A6 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
BE8900463A BE1002504A3 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE8900463A BE1002504A3 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.

Country Status (9)

Country Link
US (1) US5002939A (cs)
EP (1) EP0369216B1 (cs)
JP (1) JP2562210B2 (cs)
AT (1) ATE90563T1 (cs)
BE (2) BE1002024A6 (cs)
DE (2) DE3838716A1 (cs)
ES (1) ES2057054T3 (cs)
GR (1) GR3008170T3 (cs)
IT (1) IT1229272B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6241987B1 (en) * 1998-08-20 2001-06-05 Amway Corporation Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
EP2279196B1 (en) 2008-04-18 2015-01-21 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
WO2018042825A1 (ja) * 2016-08-30 2018-03-08 パナソニックＩｐマネジメント株式会社 色変換素子

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2201893A1 (cs) * 1972-10-06 1974-05-03 American Home Prod
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
EP0285383A2 (en) * 1987-04-03 1988-10-05 Merck & Co. Inc. Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA582813A (en) * 1959-09-08 Elks Joseph 3.beta., 12.beta.-DIHYDROXY-11-OXO-23-BROMO-5.alpha., 22.alpha.-SPIROSTAN
US3935194A (en) * 1974-01-22 1976-01-27 Omni Research Incorporated Separation of hecogenin-tigogenin mixtures
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2201893A1 (cs) * 1972-10-06 1974-05-03 American Home Prod
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
EP0285383A2 (en) * 1987-04-03 1988-10-05 Merck & Co. Inc. Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones

Also Published As

Publication number Publication date
IT1229272B (it) 1991-07-26
ATE90563T1 (de) 1993-07-15
EP0369216A2 (de) 1990-05-23
EP0369216A3 (en) 1990-11-07
JPH02180830A (ja) 1990-07-13
ES2057054T3 (es) 1994-10-16
DE58904722D1 (de) 1993-07-22
JP2562210B2 (ja) 1996-12-11
GR3008170T3 (cs) 1993-09-30
BE1002504A3 (fr) 1991-03-05
DE3838716A1 (de) 1990-05-17
DE3838716C2 (cs) 1990-09-20
IT8920466A0 (it) 1989-05-11
US5002939A (en) 1991-03-26
EP0369216B1 (de) 1993-06-16

Similar Documents

Publication Publication Date Title
FI890291A7 (fi) Menetelmä farmakologisesti aktiivisten aromaattisten estereiden ja tioestereiden valmistamiseksi
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
NO940277L (no) Triglycerider og blandinger av slike
IT8721453A0 (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche.
DE69409969D1 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
DE69328492D1 (de) Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
FI924451A7 (fi) Laite parannetun kudoshajoittamisen ja/tai hemostasian aikaansaamiseks i
BR9501404A (pt) 1H-indol-3 glioxilamida e formulação farmacèutica
FR2612187B1 (fr) Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
FI102457B1 (fi) Menetelmä probukolia sisältävän, parantuneen biosaatavuuden omaavan farmaseuttisen koostumuksen valmistamiseksi
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
SE8600496D0 (sv) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
ITMI921559A0 (it) Esteri amminoalchilcarbanici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
EP0544802A4 (en) Methods and compositions for treating t-cell mediated diseases
NO933016D0 (no) Fremgangsmaate for sikker administrering av fettsyre
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
ATE181230T1 (de) Niedrigviskose kosmetische und pharmazeutische emulsionen
FR2682598B1 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
SE8304332D0 (sv) Arzneimittel mit cytostatischer wirkung